390 related articles for article (PubMed ID: 26871598)
21. Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer.
Yan X; Jiao SC; Zhang GQ; Guan Y; Wang JL
Cancer Gene Ther; 2017 Feb; 24(2):57-63. PubMed ID: 28084319
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis.
Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I
Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338
[TBL] [Abstract][Full Text] [Related]
23. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
[TBL] [Abstract][Full Text] [Related]
24. APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC.
Li Y; Zhao X; Xiao H; Yang B; Liu J; Rao W; Dai X; Li M; Dai N; Yang Y; Wang D
BMC Cancer; 2021 Mar; 21(1):233. PubMed ID: 33676448
[TBL] [Abstract][Full Text] [Related]
25. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.
Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y
Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710
[TBL] [Abstract][Full Text] [Related]
26. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
Tao H; Mimura Y; Aoe K; Kobayashi S; Yamamoto H; Matsuda E; Okabe K; Matsumoto T; Sugi K; Ueoka H
Lung Cancer; 2012 Jan; 75(1):95-101. PubMed ID: 21719142
[TBL] [Abstract][Full Text] [Related]
27. The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Idos GE; Kwok J; Bonthala N; Kysh L; Gruber SB; Qu C
Sci Rep; 2020 Feb; 10(1):3360. PubMed ID: 32099066
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Value of Tumor Infiltrating Lymphocytes in Nasopharyngeal Carcinoma Patients: Meta-Analysis.
Berele BA; Cai Y; Yang G
Technol Cancer Res Treat; 2021; 20():15330338211034265. PubMed ID: 34323154
[TBL] [Abstract][Full Text] [Related]
29. Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer.
Liu H; Zhang T; Ye J; Li H; Huang J; Li X; Wu B; Huang X; Hou J
Cancer Immunol Immunother; 2012 Oct; 61(10):1849-56. PubMed ID: 22456757
[TBL] [Abstract][Full Text] [Related]
30. The Characteristics of Naive-like T Cells in Tumor-infiltrating Lymphocytes From Human Lung Cancer.
Sheng SY; Gu Y; Lu CG; Tang YY; Zou JY; Zhang YQ; Wang RF; Hong H
J Immunother; 2017 Jan; 40(1):1-10. PubMed ID: 27828929
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma.
Koh J; Kim S; Kim MY; Go H; Jeon YK; Chung DH
Oncotarget; 2017 Feb; 8(8):13762-13769. PubMed ID: 28099920
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer.
Park IH; Kong SY; Ro JY; Kwon Y; Kang JH; Mo HJ; Jung SY; Lee S; Lee KS; Kang HS; Lee E; Joo J; Ro J
Clin Breast Cancer; 2016 Feb; 16(1):51-8. PubMed ID: 26364145
[TBL] [Abstract][Full Text] [Related]
33. Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
Kilvaer TK; Paulsen EE; Andersen S; Rakaee M; Bremnes RM; Busund LR; Donnem T
Carcinogenesis; 2020 Dec; 41(12):1671-1681. PubMed ID: 33035322
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Significance of Tumor-infiltrating Lymphocytes on Survival Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis.
Tan HNC; Catedral LIG; San Juan MD
J Immunother; 2021 Jan; 44(1):29-40. PubMed ID: 32909965
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological and prognostic significance of FOXP3+ tumor infiltrating lymphocytes in patients with breast cancer: a meta-analysis.
Jiang D; Gao Z; Cai Z; Wang M; He J
BMC Cancer; 2015 Oct; 15():727. PubMed ID: 26475790
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of tumor-infiltrating lymphocytes in non-small cell lung cancer patients who received neoadjuvant chemotherapy followed by surgery.
Hou Z; Zhao L; Zou L; Li B
Adv Clin Exp Med; 2023 Aug; 32(8):847-853. PubMed ID: 36881364
[TBL] [Abstract][Full Text] [Related]
37. Density of tumor-infiltrating FOXP3+ T cells as a response marker for induction chemoradiotherapy and a potential prognostic factor in patients treated with trimodality therapy for locally advanced non-small cell lung cancer.
Tao H; Shien K; Soh J; Matsuda E; Toyooka S; Okabe K; Miyoshi S
Ann Thorac Cardiovasc Surg; 2014; 20(6):980-6. PubMed ID: 24583705
[TBL] [Abstract][Full Text] [Related]
38. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
[TBL] [Abstract][Full Text] [Related]
39. Objective measurement and clinical significance of TILs in non-small cell lung cancer.
Schalper KA; Brown J; Carvajal-Hausdorf D; McLaughlin J; Velcheti V; Syrigos KN; Herbst RS; Rimm DL
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25650315
[TBL] [Abstract][Full Text] [Related]
40. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer.
Shimizu K; Nakata M; Hirami Y; Yukawa T; Maeda A; Tanemoto K
J Thorac Oncol; 2010 May; 5(5):585-90. PubMed ID: 20234320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
